{
    "2019-11-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Merck, Lilly, Charter, Alibaba and Charles Schwab",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Merck",
                        "Lilly",
                        "Charter",
                        "Alibaba",
                        "Charles Schwab"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Here is What Hedge Funds Think About Eli Lilly and Company (LLY)",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Eli Lilly",
                        "Company",
                        "LLY"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}